Long-Term Challenges Persist for Survivors of High-Risk Neuroblastoma Despite Advances in Modern Therapies
Over the past two decades, the therapeutic landscape for high-risk neuroblastoma—a devastating pediatric malignancy—has undergone remarkable evolution. Traditionally, treatment was ...